Daveen Chopra - 15 Feb 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, TMTT
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 15 Feb 2023
Transactions value $: -$122,933
Form type: 4
Filing time: 15 Feb 2023, 17:20:44 UTC
Previous filing: 17 Jan 2023
Next filing: 15 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$181K	+4K	+21.15%	$45.28	22.9K	15 Feb 2023	Direct	F1
transaction	EW	Common Stock	Sale	-$304K	-4K	-17.46%	$76.01	18.9K	15 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-4K	-47.42%	$0.00	4.44K	15 Feb 2023	Common Stock	4K	$45.28	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.